Join OUP for a webinar discussing models, structures, and best practices in raising pre-seed and seed funding for university startup companies from angels and accelerators. Our panel of experts will review their own models, which are distinct from each other in both the areas in which they invest as well as the additional value they provide. Other topics covered will include raising pre-seed and seed amounts, timing and structures for the raises, how to meet with these types of investors, the roles potentially played by these investors with the startups, and much more.
Over the past several years, there’s been a proliferation of universities launching internally-driven accelerator programs, with the goal of providing inventors of early stage technologies an opportunity to develop their startup idea within an academic setting. The core concept behind a university accelerator is to offer funding, mentorship, and other resources to startups sometimes too nascent to attract seasoned talent and institutional funding. But such accelerators require large amounts of capital and an experienced team to administer programming, evaluate startups ideas, allocate funding, and provide company-building services amongst other tasks.
Recently, several universities and research institutions have set up internally driven and funded therapeutics development programs providing faculty the opportunity to push high impact translational research projects further than has been typically seen within an academic setting. These programs can oversee all stages of therapeutic discovery and development, from lab-based discovery to clinical trials. Why did these institutions decide to start these programs? How are these programs administered? What multi-disciplinary talent is needed and where did each institution find it? And perhaps most importantly, how much do these programs cost and who pays the bill?